News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Amazon Biotech Announces Letter Of Intent From A Major Medical Center To Fund Clinical Trials
December 1, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Amazon Biotech, Inc. (OTC BB: AMZB) today announced that it has a letter of intent from a major medical center to fund the Phase II and Phase III trials for Amazon Biotech, Inc.'s AIDS drug -- AMZ-0026.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Clinical research
Phase 1
Phase 2
MORE ON THIS TOPIC
IPO
2026 IPO blitz continues with 4 new biotech filings
September 22, 2026
·
4 min read
·
Tristan Manalac
Cancer
Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenics
September 22, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
BMS says goodbye to 265 New Jersey staff as reorg rolls on
September 22, 2026
·
95 min read
·
BioSpace Editorial Staff
Manufacturing
Western licensing deals for Chinese radioligand therapies to jump in 2027, Sleuth forecasts
September 21, 2026
·
2 min read
·
Nick Paul Taylor
